AXSM
Axsome Therapeutics, Inc.
Stock
$179.25−2.82 (−1.55%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $94M
- YoY, 2025
- +10.0%
- 5-year CAGR
- +44.7%
- 10-year CAGR
- +61.0%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $94M | +10.0% |
| 2024 | $85M | +36.1% |
| 2023 | $63M | +66.0% |
| 2022 | $38M | +81.3% |
| 2021 | $21M | +41.0% |
| 2020 | $15M | +141.3% |
| 2019 | $6.1M | +248.4% |
| 2018 | $1.8M | −15.3% |
| 2017 | $2.1M | +2.0% |
| 2016 | $2.0M | +152.9% |
| 2015 | $803K | +113.2% |
| 2014 | $377K | — |